These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24261031)

  • 21. Retrospective case series analysis of patients with inflammatory bowel disease on azathioprine. A district general hospital experience.
    Khan ZH; Mayberry JF; Spiers N; Wicks AC
    Digestion; 2000; 62(4):249-54. PubMed ID: 11070408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.
    Markowitz J; Grancher K; Mandel F; Daum F
    Am J Gastroenterol; 1993 Jan; 88(1):44-8. PubMed ID: 8420272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis.
    Kotlyar DS; Lewis JD; Beaugerie L; Tierney A; Brensinger CM; Gisbert JP; Loftus EV; Peyrin-Biroulet L; Blonski WC; Van Domselaar M; Chaparro M; Sandilya S; Bewtra M; Beigel F; Biancone L; Lichtenstein GR
    Clin Gastroenterol Hepatol; 2015 May; 13(5):847-58.e4; quiz e48-50. PubMed ID: 24879926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mercaptopurine-induced hepatoportal sclerosis in a patient with Crohn's disease.
    Tuyama AC; Krakauer M; Alzaabi M; Fiel MI; Legnani P; Schiano TD
    J Crohns Colitis; 2013 Aug; 7(7):590-3. PubMed ID: 22841133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Course of Nodular Regenerative Hyperplasia in Thiopurine Treated Inflammatory Bowel Disease Patients.
    Simsek M; Meijer B; Ramsoekh D; Bouma G; van der Wouden EJ; den Hartog B; de Vries AC; Hoentjen F; Dijkstra G; de Boer SY; Jansen JM; van der Meulen AE; Beukers R; Brink MA; Steinhauser T; Oldenburg B; Gilissen LP; Naber TH; Verhagen MA; de Boer NKH; Mulder CJJ;
    Clin Gastroenterol Hepatol; 2019 Feb; 17(3):568-570. PubMed ID: 29775790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Azathioprine in inflammatory bowel disease].
    Leite S; Ribeiro JM; Lima SC; Barroso S; Cotter J
    Acta Med Port; 2009; 22(1):33-40. PubMed ID: 19341591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nodular regenerative hyperplasia: a reversible entity associated with azathioprine therapy.
    Seiderer J; Zech CJ; Diebold J; Schoenberg SO; Brand S; Tillack C; Göke B; Ochsenkühn T
    Eur J Gastroenterol Hepatol; 2006 May; 18(5):553-5. PubMed ID: 16607155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Nodular regenerative hyperplasia of the liver associated with azathioprine therapy].
    Duvoux C; Kracht M; Lang P; Vernant JP; Zafrani ES; Dhumeaux D
    Gastroenterol Clin Biol; 1991; 15(12):968-73. PubMed ID: 1783253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Limited relevance and progression of histological alterations in the liver during thioguanine therapy in inflammatory bowel disease patients.
    van Asseldonk DP; Simsek M; de Boer NKH; Jharap B; Bloemena E; den Hartog G; Westerveld DB; Becx MC; Russel MG; Lissenberg-Witte BI; van Nieuwkerk CM; Mulder CJJ; Verheij J; van Bodegraven AA
    Scand J Gastroenterol; 2019 Jun; 54(6):753-760. PubMed ID: 31203688
    [No Abstract]   [Full Text] [Related]  

  • 30. Hepatic hemodynamics in 24 patients with nodular regenerative hyperplasia and symptomatic portal hypertension.
    Bissonnette J; Généreux A; Côté J; Nguyen B; Perreault P; Bouchard L; Pomier-Layrargues G
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1336-40. PubMed ID: 22554152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute pancreatitis after azathioprine treatment for ulcerative colitis.
    Tragnone A; Bazzocchi G; Aversa G; Pecorelli MG; Elmi G; Venerato S; Lanfranchi GA
    Ital J Gastroenterol; 1996; 28(2):102-4. PubMed ID: 8782004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased risk of acute myeloid leukemias and myelodysplastic syndromes in patients who received thiopurine treatment for inflammatory bowel disease.
    Lopez A; Mounier M; Bouvier AM; Carrat F; Maynadié M; Beaugerie L; Peyrin-Biroulet L;
    Clin Gastroenterol Hepatol; 2014 Aug; 12(8):1324-9. PubMed ID: 24582568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inflammatory bowel disease, azathioprine and skin cancer: case report and literature review.
    Austin AS; Spiller RC
    Eur J Gastroenterol Hepatol; 2001 Feb; 13(2):193-4. PubMed ID: 11246621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pancreatitis in inflammatory bowel diseases.
    Pitchumoni CS; Rubin A; Das K
    J Clin Gastroenterol; 2010 Apr; 44(4):246-53. PubMed ID: 20087199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nodular Regenerative Hyperplasia of the liver in Juvenile Dermatomyositis.
    Lanis A; Volochayev R; Kleiner DE; Vittal A; Heller T; Rider LG; Shenoi S
    Pediatr Rheumatol Online J; 2022 Apr; 20(1):30. PubMed ID: 35443665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study.
    Deepak P; Sifuentes H; Sherid M; Stobaugh D; Sadozai Y; Ehrenpreis ED
    Am J Gastroenterol; 2013 Jan; 108(1):99-105. PubMed ID: 23032984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of azathioprine in IBD: modern aspects of an old drug.
    Louis E; Irving P; Beaugerie L
    Gut; 2014 Nov; 63(11):1695-9. PubMed ID: 24943205
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical case of the month. Hepatoportal sclerosis in a patient treated with azathioprine].
    Roland S; Delwaide J; Cornet G; Mahieu P; Jacquet N; Belaiche J
    Rev Med Liege; 1998 Aug; 53(8):450-3. PubMed ID: 9810203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Portal hypertension in patients with inflammatory bowel disease].
    Leal-Valdivieso C; Naves JE; Mañosa M; Zabana Y; Cabré E; Domènech E
    Gastroenterol Hepatol; 2010 Apr; 33(4):297-302. PubMed ID: 20206413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Azathioprine induced hepatitis in patients with inflammatory bowel disease.
    Srirajaskanthan R; Valliani D
    Int J Clin Pharm; 2011 Oct; 33(5):724-5. PubMed ID: 21892694
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.